The Hancock Lab UBC

@[email protected]
85 Followers
42 Following
4 Posts

Dr. Bob Hancock leads research on alternative therapies for infectious disease, systems biology of innate immunity, sepsis diagnostics, and Pseudomonas. OC, OBC, FRSC. Based in the University of British Columbia, Vancouver, Canada.

Account managed by @medicurio

Lab Websitehttp://cmdr.ubc.ca/bobh/
The Hancock Lab UBCJun 17, 2023

Congratulations to Bob who has been ranked 1st in Canada and 4th in the world as one of the most cited microbiologists! #microbiology

https://research.com/scientists-rankings/microbiology

World's Best Microbiology Scientists: H-Index Microbiology Science Ranking 2023 | Research.com

Compare the best scientists in Microbiology for 2023. Discover Research.com annual Best Microbiology Scientists

Research.com
The Hancock Lab UBCJan 5, 2023

Melanie Dostert, PhD Candidate from the Hancock lab, will be presenting her exit #seminar on "Exploring the #biofilm regulatory gene network in #Pseudomonas aeruginosa using transposon insertion sequencing."

Join virtually on Zoom! http://ow.ly/G21050MjsmI

Exit Seminar - Exploring the biofilm regulatory gene network in Pseudomonas aeruginosa using transposon insertion sequencing | Microbiology & Immunology @ UBC

The Hancock Lab UBCDec 22, 2022

Bob will be chairing a discussion on therapeutic commercialization at the Antimicrobial Host Defence Peptides Conference in Italy! Taking place January 15th to 20th, 2023.

https://www.grc.org/antimicrobial-peptides-conference/2023/

#antimicrobials #peptides #biofilms #microbiology #immunology #biotech #conference

2023 Antimicrobial Peptides Conference GRC

The 2023 Gordon Research Conference on Antimicrobial Peptides will be held in Lucca (Barga), LU Italy. Apply today to reserve your spot.

The Hancock Lab UBCNov 28, 2022
The Hancock Lab's #introduction: Our lab researches #microbiology and #immunology topics from a #systemsbiology approach. Infectious disease has a massive global burden, estimated to kill over 13 million people annually, placing it as the 2nd leading cause of death. Our projects include targeting #biofilms with novel antimicrobial #peptides, understanding the mechanisms behind adaptive #antimicrobialresistance, and developing better diagnostics and treatments for #sepsis and #covid.